Parkinson's Disease Market Research Reports & Industry Analysis
As the disease progresses, the shaking, or tremor, which affects the majority of PD patients may begin to interfere with daily activities. Other symptoms may include depression and other emotional changes; difficulty in swallowing, chewing, and speaking; urinary problems or constipation; skin problems; and sleep disruptions. There are currently no blood or laboratory tests that have been proven to help in diagnosing sporadic PD. Therefore the diagnosis is based on medical history and a neurological examination. The disease can be difficult to diagnose accurately.
There is no cure for PD, but a variety of medications provide dramatic relief from the symptoms. Usually, patients are given levodopa combined with carbidopa. Carbidopa delays the conversion of levodopa into dopamine until it reaches the brain. Anticholinergics may help control tremor and rigidity. Other drugs, such as bromocriptine, pramipexole, and ropinirole, mimic the role of dopamine in the brain, causing the neurons to react as they would to dopamine. An antiviral drug, amantadine, also appears to reduce symptoms.
Parkinson's Disease Industry Research & Market Reports
-
Precision Psychiatry Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global precision psychiatry market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global precision ... Read More
-
Parkinson’s Disease Drugs
... by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Oral Route of Administration, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$4.6 ... Read More
-
Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases
... US$9.1 Billion in the year 2023, is expected to reach US$16.4 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.5 Billion While China ... Read More
-
Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
... Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Transmucosal Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about ... Read More
-
Blood Brain Barrier Market (3rd Edition): Industry Trends and Global Forecasts, till 2035
... period 2024-2035. The focus of blood-brain barrier drugs and technologies is to address the challenges posed by the selective nature of the blood-brain barrier, enabling therapeutic agents to reach the brain directly. Recent years have ... Read More
-
Mild Cognitive Impairment Market Research Report By Disease Type (Amnestic MCI and Non-Amnestic MCI), By Age (Child, Adult, Geriatric), By Indication (Lewy Body Dementia, Parkinson’s Disease Dementia, Alzheimer’s Disease, Vascular Dementia, and Others) By Treatment (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – Industry Forecast Till 2032
... (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – ... Read More
-
Dementia Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global dementia drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global dementia ... Read More
-
Neurorehabilitation Devices Market Report by Product Type (Neurorobotic Devices, Wearable Devices, Non-Invasive Stimulators, Brain-Computer Interface), Application (Stroke, Multiple Sclerosis, Parkinson's Disease, Cerebral Palsy, and Others), End User (Hospitals and Clinics, Cognitive Care Centers, and Others), and Region 2024-2032
... and Region 2024-2032 The global neurorehabilitation devices market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2032, exhibiting a growth rate (CAGR) of ... Read More
-
Global Digital Brain Health Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2032
... Region, and Segment Forecasts, 2023 – 2032 Global Digital Brain Health market was valued at US $198.1 Billion in 2022 and is expected to reach ~US $400 Billion by 2032, growing at a CAGR of ... Read More
-
Deep Brain Stimulation Devices
... reach US$2.9 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2023-2030. Dual-Channel Deep Brain Stimulation Devices, one of the segments analyzed in the report, is expected to record a 8.0% ... Read More
-
Global Deep Brain Stimulation Market: Analysis By Product (Dual Channel and Single Channel), By Application (Parkinson’s Disease, Essential Tremor, Dystonia, Epilepsy and Others), By End Use (Hospitals, Neurology Clinics, Ambulatory Surgical Clinics and Research Centers), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
... By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029 - Report Summary Report Metrics Details Years Considered 2019-2023 Base Year 2023 Forecast Period 2024-2029 Page Count 153 Units Referenced US ... Read More
-
Global Electroceutical Bioelectric Medicine Market 2024-2028
... electroceutical bioelectric medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Parkinson's Disease Related Dementia – Market Insight, Epidemiology, and Market Forecast – 2034
... Disease Related Dementia, historical and forecasted epidemiology as well as the Parkinson's Disease Related Dementia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Parkinson's Disease Related ... Read More
-
Parkinson's disease psychosis – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Parkinson's disease psychosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Parkinson's disease psychosis market report provides current ... Read More
-
Parkinson's Disease - Drug Pipeline Landscape, 2024
... from the death of cells in the substantia nigra leading to dopamine deficit. The cause of cell death involves the build-up of misfolded proteins into Lewy bodies in the neurons. Collectively known as Parkinsonian Syndrome. ... Read More
-
Parkinson's Disease Treatment
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Levodopa / Carbidopa Drug Class, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach ... Read More
-
Neurodegenerative Drugs
... at a CAGR of 4.2% over the analysis period 2023-2030. Multiple Sclerosis Drugs, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$38.3 Billion by the end ... Read More
-
2024 Global Forecast for Parkinson'S Disease (Pd) Drugs Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx ... Read More
-
2024 Global Forecast for Parkinson'S Disease Treatment Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
Neurological Disorder Drugs Market Size, Trends, Analysis, and Outlook By Disorder (Epilepsy, Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Cerebrovascular Disease, Others), By Drug (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic, Antipsychotic and Antidepressant, Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032
... Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032 The global Neurological Disorder Drugs market size is poised to register 5.2% growth from 2024 to 2032, presenting significant growth prospects for ... Read More
-
Electroceuticals Market Size, Trends, Analysis, and Outlook By Product (Implantable Cardioverter Defibrillators, Cochlear Implants, Neuromodulators, Retinal Implants), By Type (Implantable Electroceutical Devices, Noninvasive Electroceutical Devices), By Application (Arrhythmia, Depression, Parkinson’s Disease, Tremor, Epilepsy, Sensorineural Hearing Loss, Others), By End-User (Hospitals, Clinics, ASCs, Others), by Country, Segment, and Companies, 2024-2032
... Loss, Others), By End-User (Hospitals, Clinics, ASCs, Others), by Country, Segment, and Companies, 2024-2032 The global Electroceuticals market size is poised to register 7.8% growth from 2024 to 2032, presenting significant growth prospects for companies ... Read More
-
Brain Monitoring Market Size, Trends, Analysis, and Outlook By Device (Magnetic Resonance Imaging (MRI) Scanners, Computerized Tomography (CT) Scanners, Electroencephalograph (EEG) Devices, Positron Emission Tomography (PET) Scanners, Sleep Monitoring Devices, Cerebral Oximeters, Electromyography (EMG) Devices, Intracranial Pressure (ICP) Monitors, Magnetoencephalography (MEG) Devices, Transcranial Doppler (TCD) Devices), By Accessories (Electrodes, Sensors, Pastes & Gels, Caps, Cables, Batteries, Others), By Usability (Disposable, Reusable), By Procedure (Invasive Procedures, Non-invasive Procedures), By Modality (Fixed, Portable, Wearable), By Indication (Traumatic Brain Injury (TBI), Stroke, Dementia, Headache Disorders, Sleep Disorders, Parkinson’s Disease, Epilepsy, Huntington's Disease, Others), By End-User (Hospitals, Neurology Centers, Ambulatory Surgery Centers (ASCs), Diagnostic Centers, Others), by Country, Segment, and Companies, 2024-2032
... Intracranial Pressure (ICP) Monitors, Magnetoencephalography (MEG) Devices, Transcranial Doppler (TCD) Devices), By Accessories (Electrodes, Sensors, Pastes & Gels, Caps, Cables, Batteries, Others), By Usability (Disposable, Reusable), By Procedure (Invasive Procedures, Non-invasive Procedures), By Modality (Fixed, ... Read More
-
Precision Psychiatry Market Report by Product Type (Products, Services), Sample (Blood-Based, Non-Blood-Based), Biomarker Type (Genetic Biomarker, Protein Biomarker), Technology (Sequencing, Polymerase Chain Reaction (PCR), Microarray, Immunoassay, Liquid Chromatography-Mass Spectrometry (LC-MS), and Others), Application (Alzheimer’s Disease, Parkinson’s Disease, Autism, Depression, Bipolar Disease, and Others), End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutions, and Others), and Region 2024-2032
... Parkinson’s Disease, Autism, Depression, Bipolar Disease, and Others), End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutions, and Others), and Region 2024-2032 The global precision psychiatry market size reached US$ 1,059.7 Million in 2023. ... Read More
-
Gene Therapy for CNS Disorders Market Size, Trends, Analysis, and Outlook By Indication (Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, Batten Disease), By Type (Ex Vivo, In Vivo), By End-User (Hospitals, Speciality Clinics), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Gene Therapy for CNS Disorders market size is poised to register 25.24% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Central Nervous System Disorders Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Depression Drugs, Multiple Sclerosis Drugs, Schizophrenia Drugs, Bipolar Disorder Therapeutics, Epilepsy Drugs, Others), By Drug Class (Analgesics, Antidepressant, Anesthetics, Anti-Parkinson Drugs, Anti-Epileptics, Others), by Region, Country, Segment, and Companies, 2024-2030
... Others), by Region, Country, Segment, and Companies, 2024-2030 The global Central Nervous System Disorders Therapeutics market size is poised to register 6.94% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
Research Assistance
